Aligning Antimicrobial Drug Discovery with Complex and Redundant Host-Pathogen Interactions

Cell Host and Microbe

Volumn 5, Issue 2, 2009, Pages 114-122

  Lebeis, Sarah L ^a   Kalman, Daniel ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2,6 DICHLOROPHENYL) 2 [3 (HYDROXYMETHYL)ANILINO] 8 METHYLPYRIDO[2,3 D]PYRIMIDIN 7(8H) ONE; ANTIINFECTIVE AGENT; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DASATINIB; IMATINIB; KANAMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN IDR 1; PROTEIN SERP 1; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG TARGETING; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME INHIBITION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOMODULATION; MASS SPECTROMETRY; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; QUORUM SENSING; REGULATORY MECHANISM; RNA INTERFERENCE; VIRULENCE;

EID: 60649100656     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2009.01.008     Document Type: Note

References (87)

1. Agosti V., Corbacioglu S., Ehlers I., Waskow C., Sommer G., Berrozpe G., Kissel H., Tucker C.M., Manova K., Moore M.A., et al. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J. Exp. Med. 199 (2004) 867-878
2. Bedard E.L., Jiang J., Arp J., Qian H., Wang H., Guan H., Liu L., Parry N., Kim P., Garcia B., et al. Prevention of chronic renal allograft rejection by SERP-1 protein. Transplantation 81 (2006) 908-914
3. Beutler B., and Moresco M.E. The forward genetic dissection of afferent innate immunity. Curr. Top. Microb. Immunol. 321 (2008) 3-26
4. Bolz D.D., Sundsbak R.S., Ma Y., Akira S., Kirschning C.J., Zachary J.F., Weis J.H., and Weis J.J. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J. Immunol. 173 (2004) 2003-2010
5. Bommarius B., Maxwell D., Swimm A., Leung S., Corbett A., Bornmann W., and Kalman D. Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation. Mol. Microbiol. 63 (2007) 1748-1768
6. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., and Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 (2008) 921-926
7. Burton C.L., Chhabra S.R., Swift S., Baldwin T.J., Withers H., Hill S.J., and Williams P. The growth response of Escherichia coli to neurotransmitters and related catecholamine drugs requires a functional enterobactin biosynthesis and uptake system. Infect. Immun. 70 (2002) 5913-5923
8. Burton E.A., Plattner R., and Pendergast A.M. Abl tyrosine kinases are required for infection by Shigella flexneri. EMBO J. 22 (2003) 5471-5479
9. Carlton J.G., and Martin-Serrano J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316 (2007) 1908-1912
10. Chan D.C., and Kim P.S. HIV entry and its inhibition. Cell 93 (1998) 681-684
11. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
12. Coyne C.B., and Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124 (2006) 119-131
13. Dai E., Viswanathan K., Sun Y.M., Li X., Liu L.Y., Togonu-Bickersteth B., Richardson J., Macaulay C., Nash P., Turner P., et al. Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses. J. Biol. Chem. 281 (2006) 8041-8050
14. Druker B.J., Sawyers C.L., Capdeville R., Ford J.M., Baccarani M., and Goldman J.M. Chronic myelogenous leukemia. Hematology (Am Soc Hematol Educ Program) 2001 (2001) 87-112
15. Dueber J.E., Yeh B.J., Bhattacharyya R.P., and Lim W.A. Rewiring cell. signaling: the logic and plasticity of eukaryotic protein circuitry. Curr. Opin. Struct. Biol. 14 (2004) 690-699
16. Eckert D.M., Malashkevich V.N., Hong L.H., Carr P.A., and Kim P.S. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 99 (1999) 103-115
17. Elwell C.A., Ceesay A., Kim J.H., Kalman D., and Engel J.N. RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog. 4 (2008) e1000021
18. Ernst R.K., Guina T., and Miller S.I. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 3 (2001) 1327-1334
19. Fisher R.D., Chung H.Y., Zhai Q., Robinson H., Sundquist W.I., and Hill C.P. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128 (2007) 841-852
20. Frankel G., Phillips A.D., Rosenshine I., Dougan G., Kaper J.B., and Knutton S. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30 (1998) 911-921
21. Fukata M., Michelsen K.S., Eri R., Thomas L.S., Hu B., Lukasek K., Nast C.C., Lechago J., Xu R., Naiki Y., et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G1055-G1065
22. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., Hahn W.C., Ligon K.L., Louis D.N., Brennan C., et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21 (2007) 2683-2710
23. Goldman J.M., and Druker B.J. Chronic myeloid leukemia: current treatment options. Blood 98 (2001) 2039-2042
24. Hancock R.E., and Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24 (2006) 1551-1557
25. Heinrich M.C., Griffith D.J., Druker B.J., Wait C.L., Ott K.A., and Zigler A.J. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96 (2000) 925-932
26. Hirsch A.J., Medigeshi G.R., Meyers H.L., DeFilippis V., Fruh K., Briese T., Lipkin W.I., and Nelson J.A. The Src family kinase c-Yes is required for maturation of West Nile virus particles. J. Virol. 79 (2005) 11943-11951
27. Hughes D.T., and Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat. Rev. Microbiol. 6 (2008) 111-120
28. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
29. Hurley J.H., and Emr S.D. The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu. Rev. Biophys. Biomol. Struct. 35 (2006) 277-298
30. Jiang J., Arp J., Kubelik D., Zassoko R., Liu W., Wise Y., Macaulay C., Garcia B., McFadden G., Lucas A.R., and Wang H. Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-1 (Serp-1) treatment. Transplantation 84 (2007) 1158-1167
31. Jin T., Bokarewa M., Foster T., Mitchell J., Higgins J., and Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172 (2004) 1169-1176
32. Kaisho T., and Akira S. Pleiotropic function of Toll-like receptors. Microbes Infect. 6 (2004) 1388-1394
33. Kaper J.B., and Sperandio V. Bacterial cell-to-cell signaling in the gastrointestinal tract. Infect. Immun. 73 (2005) 3197-3209
34. Karch H., Tarr P.I., and Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295 (2005) 405-418
35. Kendall M.M., and Sperandio V. Quorum sensing by enteric pathogens. Curr. Opin. Gastroenterol. 23 (2007) 10-15
36. Kerkela R., Grazette L., Yacobi R., Iliescu C., Patten R., Beahm C., Walters B., Shevtsov S., Pesant S., Clubb F.J., et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat. Med. 12 (2006) 908-916
37. Khakoo A.Y., Kassiotis C.M., Tannir N., Plana J.C., Halushka M., Bickford C., Trent II J., Champion J.C., Durand J.B., and Lenihan D.J. Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor. Cancer 112 (2008) 2500-2508
38. Kim J.E., and White F.M. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J. Immunol. 176 (2006) 2833-2843
39. Koenig R. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination. Science 319 (2008) 894-897
40. Kufer T.A., and Sansonetti P.J. Sensing of bacteria: NOD a lonely job. Curr. Opin. Microbiol. 10 (2007) 62-69
41. Kumar N., Wolf-Yadlin A., White F.M., and Lauffenburger D.A. Modeling HER2 Effects on Cell Behavior from Mass Spectrometry Phosphotyrosine Data. PLoS Comput. Biol. 3 (2007) e4
42. Laub M.T., and Goulian M. Specificity in two-component signal transduction pathways. Annu. Rev. Genet. 41 (2007) 121-145
43. Lebeis S.L., Bommarius B., Parkos C.A., Sherman M.A., and Kalman D. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J. Immunol. 179 (2007) 566-577
44. Luperchio S.A., and Schauer D.B. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3 (2001) 333-340
45. Ly K.T., and Casanova J.E. Abelson Tyrosine Kinase Facilitates Salmonella enterica serovar Typhimurium Entry into Epithelial Cells. Infect. Immun. 77 (2008) 60-69
46. Mahajan-Miklos S., Tan M.W., Rahme L.G., and Ausubel F.M. Molecular mechanisms of Bacterial Virulence Elucidated Using a Pseudomonas aeruginosa-Caenorhabditis elegans Pathogenesis Model. Cell 96 (1999) 47-56
47. Mann D.L. Targeted cancer therapeutics: the heartbreak of success. Nat. Med. 12 (2006) 881-882
48. Marr A.K., Gooderham W.J., and Hancock R.E. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6 (2006) 468-472
49. McAllister S.C., Fruh K., and Moses A.V. Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma. Pharmacogenomics 6 (2005) 235-244
50. McDaniel T.K., Jarvis K.G., Donnenberg M.S., and Kaper J.B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA 92 (1995) 1664-1668
51. Merighi M., Carroll-Portillo A., Septer A.N., Bhatiya A., and Gunn J.S. Role of Salmonella enterica serovar Typhimurium two-component system PreA/PreB in modulating PmrA-regulated gene transcription. J. Bacteriol. 188 (2006) 141-149
52. Moon H.W., Whipp S.C., Argenzio R.A., Levine M.M., and Giannella R.A. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect. Immun. 41 (1983) 1340-1351
53. Morita E., Sandrin V., Chung H.Y., Morham S.G., Gygi S.P., Rodesch C.K., and Sundquist W.I. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 26 (2007) 4215-4227
54. Nealson K.H., Platt T., and Hastings J.W. Cellular control of the synthesis and activity of the bacterial luminescent system. J. Bacteriol. 104 (1970) 313-322
55. Newsome T.P., Scaplehorn N., and Way M. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 306 (2004) 124-129
56. Paul R., Jaeger T., Abel S., Wiederkehr I., Folcher M., Biondi E.G., Laub M.T., and Jenal U. Allosteric regulation of histidine kinases by their cognate response regulator determines cell fate. Cell 133 (2008) 452-461
57. Peschel A. How do bacteria resist human antimicrobial peptides?. Trends Microbiol. 10 (2002) 179-186
58. Philpott D.J., and Girardin S.E. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol. Immunol. 41 (2004) 1099-1108
59. Pielage J.F., Powell K.R., Kalman D., and Engel J.N. RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization. PLoS Pathog. 4 (2008) e1000031
60. Porta C., Paglino C., Imarisio I., and Bonomi L. Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib. Clin. Exp. Med. 7 (2007) 127-134
61. Pouessel D., and Culine S. High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. Eur. Urol. 53 (2008) 376-381
62. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
63. Rasko D.A., Moreira C.G., Li, de R., Reading N.C., Ritchie J.M., Waldor M.K., Williams N., Taussig R., Wei S., Roth M., et al. Targeting QseC signaling and virulence for antibiotic development. Science 321 (2008) 1078-1080
64. Reading N.C., and Sperandio V. Quorum sensing: the many languages of bacteria. FEMS Microbiol. Lett. 254 (2006) 1-11
65. Reading N.C., Torres A.G., Kendall M.M., Hughes D.T., Yamamoto K., and Sperandio V. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J. Bacteriol. 189 (2007) 2468-2476
66. Reeves P.M., Bommarius B., Lebeis S., McNulty S., Christensen J., Swimm A., Chahroudi A., Chavan R., Feinberg M.B., Veach D., et al. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 11 (2005) 731-739
67. Richardson J., Viswanathan K., and Lucas A. Serpins, the vasculature, and viral therapeutics. Front. Biosci. 11 (2006) 1042-1056
68. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3 (2004) 1154-1169
69. Sahl H.G., Pag U., Bonness S., Wagner S., Antcheva N., and Tossi A. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77 (2005) 466-475
70. Scott M.G., Dullaghan E., Mookherjee N., Glavas N., Waldbrook M., Thompson A., Wang A., Lee K., Doria S., Hamill P., et al. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25 (2007) 465-472
71. Shafer W.M., Qu X., Waring A.J., and Lehrer R.I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 95 (1998) 1829-1833
72. Shah N.P., Tran C., Lee F.Y., Chen P., Norris D., and Sawyers C.L. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 305 (2004) 399-401
73. Sperandio V., Torres A.G., Jarvis B., Nataro J.P., and Kaper J.B. Bacteria-host communication: the language of hormones. Proc. Natl. Acad. Sci. USA 100 (2003) 8951-8956
74. Stommel J.M., Kimmelman A.C., Ying H., Nabioullin R., Ponugoti A.H., Wiedemeyer R., Stegh A.H., Bradner J.E., Ligon K.L., Brennan C., et al. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318 (2007) 287-290
75. Swimm A., Bommarius B., Li Y., Cheng D., Reeves P., Sherman M., Veach D., Bornmann W., and Kalman D. Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol. Biol. Cell 15 (2004) 3520-3529
76. Takada H., Yokoyama S., and Yang S. Enhancement of endotoxin activity by muramyldipeptide. J. Endotoxin Res. 8 (2002) 337-342
77. Tammer I., Brandt S., Hartig R., Konig W., and Backert S. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132 (2007) 1309-1319
78. Traxler P., Bold G., Buchdunger E., Caravatti G., Furet P., Manley P., O'Reilly T., Wood J., and Zimmermann J. Tyrosine kinase inhibitors: from rational design to clinical trials. Med. Res. Rev. 21 (2001) 499-512
79. Turner P.C., and Moyer R.W. Poxvirus immune modulators: functional insights from animal models. Virus Res. 88 (2002) 35-53
80. von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., et al. The protein network of HIV budding. Cell 114 (2003) 701-713
81. Waldor M.K., and Sperandio V. Adrenergic regulation of bacterial virulence. J. Infect. Dis. 195 (2007) 1248-1249
82. Weiss D.S., Takeda K., Akira S., Zychlinsky A., and Moreno E. MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus. Infect. Immun. 73 (2005) 5137-5143
83. Williams S.C., Patterson E.K., Carty N.L., Griswold J.A., Hamood A.N., and Rumbaugh K.P. Pseudomonas aeruginosa autoinducer enters and functions in mammalian cells. J. Bacteriol. 186 (2004) 2281-2287
84. Woolhouse M.E., Webster J.P., Domingo E., Charlesworth B., and Levin B.R. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 32 (2002) 569-577
85. Zamborlini A., Usami Y., Radoshitzky S.R., Popova E., Palu G., and Gottlinger H. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc. Natl. Acad. Sci. USA 103 (2006) 19140-19145
86. Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J., Lauffenburger D.A., and White F.M. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4 (2005) 1240-1250
87. Zhou S., Kurt-Jones E.A., Mandell L., Cerny A., Chan M., Golenbock D.T., and Finberg R.W. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35 (2005) 822-830